Effect of partially modified retro‐inverso analogues derived from C‐reactive protein on the induction of nitric oxide synthesis in peritoneal macrophages
暂无分享,去创建一个
F. Marcucci | E Cillari | G. Gromo | F. Leoni | F Marcucci | F Arcoleo | S Milano | P D'Agostino | G Misiano | S Cappelletti | G Gromo | F Leoni | E. Cillari | S. Milano | P. D’Agostino | F. Arcoleo | G. Misiano | S. Cappelletti
[1] J. Lancaster,et al. Synthesis of nitric oxide from a terminal guanidino nitrogen atom of L-arginine: A molecular mechanism regulating cellular proliferation that targets intracellular iron , 1990 .
[2] K. Nishioka,et al. Effect of Tuftsin on the Migration, Chemotaxis, and Differentiation of Macrophages and Granulocytes a , 1983, Annals of the New York Academy of Sciences.
[3] M. Krönke,et al. Functional dichotomy of neutral and acidic sphingomyelinases in tumor necrosis factor signaling , 1994, Cell.
[4] G. Gromo,et al. The macrophage-activating tetrapeptide tuftsin induces nitric oxide synthesis and stimulates murine macrophages to kill Leishmania parasites in vitro , 1994, Infection and immunity.
[5] J. Drapier,et al. Interferon‐γ and tumor necrosis factor induce the L‐arginine‐dependent cytotoxic effector mechanism in murine macrophages* , 1988 .
[6] P. Gottlieb,et al. Tuftsin, Thr-Lys-Pro-Arg , 1981 .
[7] C. Nathan,et al. Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production. , 1988, Journal of immunology.
[8] M. Salter,et al. Widespread tissue distribution, species distribution and changes in activity of Ca2+‐dependent and Ca2+‐independent nitric oxide synthases , 1991, FEBS letters.
[9] A. Baldwin,et al. THE NF-κB AND IκB PROTEINS: New Discoveries and Insights , 1996 .
[10] P. Baeuerle,et al. Function and activation of NF-kappa B in the immune system. , 1994, Annual review of immunology.
[11] I. Kushner,et al. SERUM C‐REACTIVE PROTEIN LEVELS IN DISEASE * , 1982, Annals of the New York Academy of Sciences.
[12] G. Rovati,et al. Lower efficacy: interaction with an inhibitory receptor or partial agonism? , 1994, Trends in pharmacological sciences.
[13] M. Witko,et al. Quantum-chemistry and catalysis in oxidation of hydrocarbons , 1981 .
[14] G. Nabel,et al. Tumor necrosis factor alpha and interleukin 1 stimulate the human immunodeficiency virus enhancer by activation of the nuclear factor kappa B. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[15] T. Lint,et al. Interaction of C-reactive protein with lymphocytes and monocytes: complement-dependent adherence and phagocytosis. , 1976, Journal of immunology.
[16] P. Baeuerle. Dithiocarbamates as Potent Inhibitors of Nuclear Factor KB Activation in Intact Cells By galf Schreck, Beate Meier,* Daniela N. M~innel,~ Wulf Dr6ge,~ , 1992 .
[17] M. Fridkin,et al. The effect of Tuftsin on the nitrous blue tetrazolium reduction of normal human polymorphonuclear leukocytes. , 1975, The Journal of clinical investigation.
[18] K. Nishioka,et al. Tuftsin: a hormone-like tetrapeptide with antimicrobial and antitumor activities. , 1981, Life sciences.
[19] B. Fiedel. Influence of tuftsin-like synthetic peptides derived from C-reactive protein (CRP) on platelet behaviour. , 1988, Immunology.
[20] B. Brenner,et al. Interleukin 1 induces prolonged L-arginine-dependent cyclic guanosine monophosphate and nitrite production in rat vascular smooth muscle cells. , 1991, The Journal of clinical investigation.
[21] M. Fridkin,et al. Tuftsin: its chemistry, biology, and clinical potential. , 1989, Critical reviews in biochemistry and molecular biology.
[22] V. Pliska. Models to explain dose-response relationships that exhibit a downturn phase. , 1994, Trends in pharmacological sciences.
[23] A. Levitzki,et al. Prevention of lipopolysaccharide-induced lethal toxicity by tyrosine kinase inhibitors. , 1994, Science.
[24] R. Heuertz,et al. Peptides derived from C-reactive protein inhibit neutrophil alveolitis. , 1996, Journal of immunology.
[25] M. Pepys,et al. Acute phase proteins with special reference to C-reactive protein and related proteins (pentaxins) and serum amyloid A protein. , 1983, Advances in immunology.
[26] S. Futaki,et al. Proteolysis of human C-reactive protein produces peptides with potent immunomodulating activity. , 1987, The Journal of biological chemistry.
[27] P. Libby,et al. Induction and Stabilization of IκBα by Nitric Oxide Mediates Inhibition of NF-κB (*) , 1995, The Journal of Biological Chemistry.
[28] W. Greene,et al. Tumor necrosis factor alpha induces proteins that bind specifically to kappa B-like enhancer elements and regulate interleukin 2 receptor alpha-chain gene expression in primary human T lymphocytes. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[29] D. Männel,et al. Dithiocarbamates as potent inhibitors of nuclear factor kappa B activation in intact cells , 1992, The Journal of experimental medicine.
[30] K. Nishioka,et al. Prophylaxis of Candida albicans infection with tuftsin. , 1986, Journal of Antimicrobial Chemotherapy.
[31] P. Majerus,et al. Inositol Hexakisphosphate Binds to Clathrin Assembly Protein 3 (AP-3/AP180) and Inhibits Clathrin Cage Assembly in Vitro(*) , 1995, The Journal of Biological Chemistry.
[32] K. Nishioka,et al. ‘Tuftsin’: a Natural Phagocytosis Stimulating Peptide , 1970, Nature.
[33] I. Kushner,et al. C-reactive protein and the acute-phase response. , 1990, Hospital practice.
[34] T. Mosmann. Rapid colorimetric assay for cellular growth and survival: application to proliferation and cytotoxicity assays. , 1983, Journal of immunological methods.
[35] Murray Goodman,et al. On the Concept of Linear Modified Retro-Peptide Structures , 1979 .
[36] C. Nathan,et al. Identification of arginine as a precursor of endothelium-derived relaxing factor. , 1988, Proceedings of the National Academy of Sciences of the United States of America.
[37] M. Longobardi,et al. Immunostimulation by a partially modified retro-inverso-tuftsin analogue containing Thr1 psi[NHCO](R,S)Lys2 modification. , 1991, Journal of medicinal chemistry.
[38] B. Huber,et al. Interleukin‐1 induces c‐fos and c‐jun gene expression in T helper type II cells through different signal transmission pathways , 1992, European journal of immunology.
[39] R. Busse,et al. Nitric oxide modulates the expression of monocyte chemoattractant protein 1 in cultured human endothelial cells. , 1995, Circulation research.
[40] F. Bonelli,et al. Solid phase synthesis of retro-inverso peptide analogues. Synthesis and biological activity of the partially modified retro-inverso analogue of the bradykinin potentiating peptide BPP9a [gLys6, (RS)-mPhe7, Ala8] BPP9a. , 2009, International journal of peptide & protein research.
[41] U. K. Laemmli,et al. Cleavage of Structural Proteins during the Assembly of the Head of Bacteriophage T4 , 1970, Nature.
[42] J. Robotham,et al. The acute-phase response. , 1995, New horizons.
[43] Z. Fuks,et al. Toxicology and Antitumor Activity of Tuftsin a , 1983, Annals of the New York Academy of Sciences.
[44] J. Volanakis,et al. Probing the C1q-binding site on human C-reactive protein by site-directed mutagenesis. , 1994, Journal of immunology.
[45] A. Whitehead,et al. The major acute phase reactants: C-reactive protein, serum amyloid P component and serum amyloid A protein. , 1994, Immunology today.
[46] P. Kaumaya,et al. Cell attachment peptide of C‐reactive protein: critical amino acids and minimum length , 1994, Journal of cellular biochemistry.
[47] M. Ginsberg,et al. Arginyl-glycyl-aspartic acid (RGD): a cell adhesion motif. , 1991, Trends in biochemical sciences.
[48] S. Moncada,et al. Vascular endothelial cells synthesize nitric oxide from L-arginine , 1988, Nature.